Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients With Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab. 2019 Sep 23;[EPub Ahead of Print], FS Yen, HC Wang, CW Pan, JC Wei, CC Hsu, CM HwuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.